| Date | TitleTitle | ||||
|---|---|---|---|---|---|
| 29/01/26 | 07:00:10 | 29 Jan 2026 | Holding(s) in Company | RNS | |
| 20/01/26 | 12:36:01 | 20 Jan 2026 | Holding(s) in Company | RNS | |
| 14/01/26 | 07:00:09 | 14 Jan 2026 | Directorate change | RNS | |
| 14/01/26 | 07:00:09 | 14 Jan 2026 | Holding(s) in Company | RNS | |
| 12/01/26 | 18:25:57 | 12 Jan 2026 | Holding(s) in Company | RNS | |
| 07/01/26 | 14:06:01 | 7 Jan 2026 | Pulmocide announces termination of Phase 3 study | RNS | |
| 02/01/26 | 07:00:05 | 2 Jan 2026 | Holding(s) in Company | RNS | |
| 18/12/25 | 16:13:14 | 18 Dec 2025 | Holding(s) in Company | RNS | |
| 08/12/25 | 07:00:02 | 8 Dec 2025 | Holding(s) in Company | RNS | |
| 05/12/25 | 17:26:22 | 5 Dec 2025 | Holding(s) in Company | RNS | |
| 04/12/25 | 16:13:20 | 4 Dec 2025 | Holding(s) in Company | RNS | |
| 01/12/25 | 17:37:03 | 1 Dec 2025 | Total Voting Rights | RNS | |
| 20/11/25 | 07:00:15 | 20 Nov 2025 | Completion of share buyback programme | RNS | |
| 19/11/25 | 07:00:03 | 19 Nov 2025 | Transaction in Own Shares | RNS | |
| 18/11/25 | 07:00:03 | 18 Nov 2025 | Transaction in Own Shares | RNS | |
| 17/11/25 | 13:10:00 | 17 Nov 2025 | Artios completes oversubscribed $115m financing | RNS | |
| 14/11/25 | 17:47:58 | 14 Nov 2025 | Transaction in Own Shares | RNS | |
| 14/11/25 | 08:20:15 | 14 Nov 2025 | Holding(s) in Company | RNS | |
| 14/11/25 | 07:00:05 | 14 Nov 2025 | Transaction in Own Shares | RNS | |
| 13/11/25 | 16:09:43 | 13 Nov 2025 | Holding(s) in Company | RNS | |
| 13/11/25 | 07:00:06 | 13 Nov 2025 | Transaction in Own Shares | RNS | |
| 12/11/25 | 07:00:09 | 12 Nov 2025 | Transaction in Own Shares | RNS | |
| 11/11/25 | 16:45:40 | 11 Nov 2025 | Holding(s) in Company | RNS | |
| 10/11/25 | 18:02:10 | 10 Nov 2025 | Transaction in Own Shares | RNS | |
| 10/11/25 | 07:00:03 | 10 Nov 2025 | Transaction in Own Shares | RNS | |
| 07/11/25 | 16:51:52 | 7 Nov 2025 | Holding(s) in Company | RNS | |
| 07/11/25 | 07:00:03 | 7 Nov 2025 | Transaction in Own Shares | RNS | |
| 06/11/25 | 07:00:08 | 6 Nov 2025 | Transaction in Own Shares | RNS | |
| 05/11/25 | 17:14:19 | 5 Nov 2025 | Holding(s) in Company | RNS | |
| 04/11/25 | 18:23:02 | 4 Nov 2025 | Transaction in Own Shares | RNS | |
| 04/11/25 | 07:00:03 | 4 Nov 2025 | Transaction in Own Shares | RNS | |
| 31/10/25 | 17:25:17 | 31 Oct 2025 | Total Voting Rights | RNS | |
| 31/10/25 | 17:19:41 | 31 Oct 2025 | Transaction in Own Shares | RNS | |
| 31/10/25 | 07:00:08 | 31 Oct 2025 | Transaction in Own Shares | RNS | |
| 29/10/25 | 17:27:59 | 29 Oct 2025 | Transaction in Own Shares | RNS | |
| 28/10/25 | 18:06:06 | 28 Oct 2025 | Transaction in Own Shares | RNS | |
| 28/10/25 | 07:00:06 | 28 Oct 2025 | Transaction in Own Shares | RNS | |
| 24/10/25 | 17:31:08 | 24 Oct 2025 | Transaction in Own Shares | RNS | |
| 24/10/25 | 07:00:04 | 24 Oct 2025 | Transaction in Own Shares | RNS | |
| 22/10/25 | 17:30:57 | 22 Oct 2025 | Transaction in Own Shares | RNS | |
| 22/10/25 | 07:00:05 | 22 Oct 2025 | Transaction in Own Shares | RNS | |
| 21/10/25 | 07:00:05 | 21 Oct 2025 | Transaction in Own Shares | RNS | |
| 17/10/25 | 17:59:36 | 17 Oct 2025 | Transaction in Own Shares | RNS | |
| 16/10/25 | 17:45:29 | 16 Oct 2025 | Transaction in Own Shares | RNS | |
| 15/10/25 | 17:20:29 | 15 Oct 2025 | Transaction in Own Shares | RNS | |
| 15/10/25 | 07:00:06 | 15 Oct 2025 | Transaction in Own Shares | RNS | |
| 14/10/25 | 18:18:06 | 14 Oct 2025 | Holding(s) in Company | RNS | |
| 13/10/25 | 07:00:11 | 13 Oct 2025 | Potential income from Metsera obesity drugs | RNS | |
| 10/10/25 | 17:17:32 | 10 Oct 2025 | Transaction in Own Shares | RNS | |
| 10/10/25 | 07:00:05 | 10 Oct 2025 | Transaction in Own Shares | RNS |
| Date | TitleTitle | ||||
|---|---|---|---|---|---|
| 29/01/26 | 07:00:10 | 29 Jan 2026 | Holding(s) in Company | RNS | |
| 20/01/26 | 12:36:01 | 20 Jan 2026 | Holding(s) in Company | RNS | |
| 14/01/26 | 07:00:09 | 14 Jan 2026 | Directorate change | RNS | |
| 14/01/26 | 07:00:09 | 14 Jan 2026 | Holding(s) in Company | RNS | |
| 12/01/26 | 18:25:57 | 12 Jan 2026 | Holding(s) in Company | RNS | |
| 07/01/26 | 14:06:01 | 7 Jan 2026 | Pulmocide announces termination of Phase 3 study | RNS | |
| 02/01/26 | 07:00:05 | 2 Jan 2026 | Holding(s) in Company | RNS | |
| 18/12/25 | 16:13:14 | 18 Dec 2025 | Holding(s) in Company | RNS | |
| 08/12/25 | 07:00:02 | 8 Dec 2025 | Holding(s) in Company | RNS | |
| 05/12/25 | 17:26:22 | 5 Dec 2025 | Holding(s) in Company | RNS | |
| 04/12/25 | 16:13:20 | 4 Dec 2025 | Holding(s) in Company | RNS | |
| 01/12/25 | 17:37:03 | 1 Dec 2025 | Total Voting Rights | RNS | |
| 20/11/25 | 07:00:15 | 20 Nov 2025 | Completion of share buyback programme | RNS | |
| 19/11/25 | 07:00:03 | 19 Nov 2025 | Transaction in Own Shares | RNS | |
| 18/11/25 | 07:00:03 | 18 Nov 2025 | Transaction in Own Shares | RNS | |
| 17/11/25 | 13:10:00 | 17 Nov 2025 | Artios completes oversubscribed $115m financing | RNS | |
| 14/11/25 | 17:47:58 | 14 Nov 2025 | Transaction in Own Shares | RNS | |
| 14/11/25 | 08:20:15 | 14 Nov 2025 | Holding(s) in Company | RNS | |
| 14/11/25 | 07:00:05 | 14 Nov 2025 | Transaction in Own Shares | RNS | |
| 13/11/25 | 16:09:43 | 13 Nov 2025 | Holding(s) in Company | RNS | |
| 13/11/25 | 07:00:06 | 13 Nov 2025 | Transaction in Own Shares | RNS | |
| 12/11/25 | 07:00:09 | 12 Nov 2025 | Transaction in Own Shares | RNS | |
| 11/11/25 | 16:45:40 | 11 Nov 2025 | Holding(s) in Company | RNS | |
| 10/11/25 | 18:02:10 | 10 Nov 2025 | Transaction in Own Shares | RNS | |
| 10/11/25 | 07:00:03 | 10 Nov 2025 | Transaction in Own Shares | RNS | |
| 07/11/25 | 16:51:52 | 7 Nov 2025 | Holding(s) in Company | RNS | |
| 07/11/25 | 07:00:03 | 7 Nov 2025 | Transaction in Own Shares | RNS | |
| 06/11/25 | 07:00:08 | 6 Nov 2025 | Transaction in Own Shares | RNS | |
| 05/11/25 | 17:14:19 | 5 Nov 2025 | Holding(s) in Company | RNS | |
| 04/11/25 | 18:23:02 | 4 Nov 2025 | Transaction in Own Shares | RNS | |
| 04/11/25 | 07:00:03 | 4 Nov 2025 | Transaction in Own Shares | RNS | |
| 31/10/25 | 17:25:17 | 31 Oct 2025 | Total Voting Rights | RNS | |
| 31/10/25 | 17:19:41 | 31 Oct 2025 | Transaction in Own Shares | RNS | |
| 31/10/25 | 07:00:08 | 31 Oct 2025 | Transaction in Own Shares | RNS | |
| 29/10/25 | 17:27:59 | 29 Oct 2025 | Transaction in Own Shares | RNS | |
| 28/10/25 | 18:06:06 | 28 Oct 2025 | Transaction in Own Shares | RNS | |
| 28/10/25 | 07:00:06 | 28 Oct 2025 | Transaction in Own Shares | RNS | |
| 24/10/25 | 17:31:08 | 24 Oct 2025 | Transaction in Own Shares | RNS | |
| 24/10/25 | 07:00:04 | 24 Oct 2025 | Transaction in Own Shares | RNS | |
| 22/10/25 | 17:30:57 | 22 Oct 2025 | Transaction in Own Shares | RNS | |
| 22/10/25 | 07:00:05 | 22 Oct 2025 | Transaction in Own Shares | RNS | |
| 21/10/25 | 07:00:05 | 21 Oct 2025 | Transaction in Own Shares | RNS | |
| 17/10/25 | 17:59:36 | 17 Oct 2025 | Transaction in Own Shares | RNS | |
| 16/10/25 | 17:45:29 | 16 Oct 2025 | Transaction in Own Shares | RNS | |
| 15/10/25 | 17:20:29 | 15 Oct 2025 | Transaction in Own Shares | RNS | |
| 15/10/25 | 07:00:06 | 15 Oct 2025 | Transaction in Own Shares | RNS | |
| 14/10/25 | 18:18:06 | 14 Oct 2025 | Holding(s) in Company | RNS | |
| 13/10/25 | 07:00:11 | 13 Oct 2025 | Potential income from Metsera obesity drugs | RNS | |
| 10/10/25 | 17:17:32 | 10 Oct 2025 | Transaction in Own Shares | RNS | |
| 10/10/25 | 07:00:05 | 10 Oct 2025 | Transaction in Own Shares | RNS |
